Brief: Elevation Oncology Announces Planned Combination Strategy

Elevation Oncology

27/06/2024 12:39

June 27 (Reuters) - Elevation Oncology Inc  ELEV.O :
    * ELEVATION ONCOLOGY ANNOUNCES PLANNED COMBINATION STRATEGY
FOR
EO-3021 IN PATIENTS WITH GASTRIC OR GASTROESOPHAGEAL JUNCTION
CANCER
    * ELEVATION ONCOLOGY INC - TO EXPAND PHASE 1 TRIAL FOR
EO-3021
    * ELEVATION ONCOLOGY INC - EXPECT TO INITIATE DOSING IN
COMBINATION PORTION OF PHASE 1 TRIAL BY YEAR-END 2024
    * ELEVATION ONCOLOGY INC: ON-TRACK TO PROVIDE UPDATE FROM
ONGOING
PHASE 1 CLINICAL TRIAL EVALUATING MONOTHERAPY EO-3021 BY MID-3Q
2024

Source text for Eikon:  ID:nPnbBQVR5a 
Further company coverage:  ELEV.O 

 ((Reuters.Briefs@thomsonreuters.com;))